A citation-based method for searching scientific literature

Katrin Sangkuhl, Karla Claudio-Campos, Larisa H Cavallari, Jose A G Agundez, Michelle Whirl-Carrillo, Jorge Duconge, Andria L Del Tredici, Mia Wadelius, Mariana Rodrigues Botton, Erica L Woodahl, Stuart A Scott, Teri E Klein, Victoria M Pratt, Ann K Daly, Andrea Gaedigk. Clin Pharmacol Ther 2021
Times Cited: 7







List of co-cited articles
17 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


PharmVar GeneFocus: CYP2C19.
Mariana R Botton, Michelle Whirl-Carrillo, Andria L Del Tredici, Katrin Sangkuhl, Larisa H Cavallari, José A G Agúndez, Jorge Duconge, Ming Ta Michael Lee, Erica L Woodahl, Karla Claudio-Campos,[...]. Clin Pharmacol Ther 2021
20
57

PharmVar GeneFocus: CYP2D6.
Charity Nofziger, Amy J Turner, Katrin Sangkuhl, Michelle Whirl-Carrillo, José A G Agúndez, John L Black, Henry M Dunnenberger, Gualberto Ruano, Martin A Kennedy, Michael S Phillips,[...]. Clin Pharmacol Ther 2020
72
57

PharmVar GeneFocus: CYP2B6.
Zeruesenay Desta, Ahmed El-Boraie, Li Gong, Andrew A Somogyi, Volker M Lauschke, Collet Dandara, Kathrin Klein, Neil A Miller, Teri E Klein, Rachel F Tyndale,[...]. Clin Pharmacol Ther 2021
9
42

The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database.
Andrea Gaedigk, Magnus Ingelman-Sundberg, Neil A Miller, J Steven Leeder, Michelle Whirl-Carrillo, Teri E Klein. Clin Pharmacol Ther 2018
183
42

Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.
Victoria M Pratt, Robin E Everts, Praful Aggarwal, Brittany N Beyer, Ulrich Broeckel, Ruth Epstein-Baak, Paul Hujsak, Ruth Kornreich, Jun Liao, Rachel Lorier,[...]. J Mol Diagn 2016
71
42

The Evolution of PharmVar.
Andrea Gaedigk, Katrin Sangkuhl, Michelle Whirl-Carrillo, Greyson P Twist, Teri E Klein, Neil A Miller. Clin Pharmacol Ther 2019
67
42

Pharmacogene Variation Consortium Gene Introduction: NUDT15.
Jun J Yang, Michelle Whirl-Carrillo, Stuart A Scott, Amy J Turner, Matthias Schwab, Yoichi Tanaka, Guilherme Suarez-Kurtz, Elke Schaeffeler, Teri E Klein, Neil A Miller,[...]. Clin Pharmacol Ther 2019
30
28

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.
Craig R Lee, Joyce A Goldstein, John A Pieper. Pharmacogenetics 2002
499
28

Discovery of new potentially defective alleles of human CYP2C9.
Joyce Blaisdell, Lucia F Jorge-Nebert, Sherry Coulter, Stephen S Ferguson, Su-Jun Lee, Brian Chanas, Tina Xi, Harvey Mohrenweiser, Burhan Ghanayem, Joyce A Goldstein. Pharmacogenetics 2004
135
28

Calling Star Alleles With Stargazer in 28 Pharmacogenes With Whole Genome Sequences.
Seung-Been Lee, Marsha M Wheeler, Kenneth E Thummel, Deborah A Nickerson. Clin Pharmacol Ther 2019
26
28

PGRNseq: a targeted capture sequencing panel for pharmacogenetic research and implementation.
Adam S Gordon, Robert S Fulton, Xiang Qin, Elaine R Mardis, Deborah A Nickerson, Steve Scherer. Pharmacogenet Genomics 2016
73
28

The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later.
Mary V Relling, Teri E Klein, Roseann S Gammal, Michelle Whirl-Carrillo, James M Hoffman, Kelly E Caudle. Clin Pharmacol Ther 2020
70
28

Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data.
Xiao Chen, Fei Shen, Nina Gonzaludo, Alka Malhotra, Cande Rogert, Ryan J Taft, David R Bentley, Michael A Eberle. Pharmacogenomics J 2021
13
28

StellarPGx: A Nextflow Pipeline for Calling Star Alleles in Cytochrome P450 Genes.
David Twesigomwe, Britt I Drögemöller, Galen E B Wright, Azra Siddiqui, Jorge da Rocha, Zané Lombard, Scott Hazelhurst. Clin Pharmacol Ther 2021
4
50

Allelic decomposition and exact genotyping of highly polymorphic and structurally variant genes.
Ibrahim Numanagić, Salem Malikić, Michael Ford, Xiang Qin, Lorraine Toji, Milan Radovich, Todd C Skaar, Victoria M Pratt, Bonnie Berger, Steve Scherer,[...]. Nat Commun 2018
30
28

Recommendations for Clinical CYP2C9 Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists.
Victoria M Pratt, Larisa H Cavallari, Andria L Del Tredici, Houda Hachad, Yuan Ji, Ann M Moyer, Stuart A Scott, Michelle Whirl-Carrillo, Karen E Weck. J Mol Diagn 2019
44
28

Recommendations for Clinical CYP2C19 Genotyping Allele Selection: A Report of the Association for Molecular Pathology.
Victoria M Pratt, Andria L Del Tredici, Houda Hachad, Yuan Ji, Lisa V Kalman, Stuart A Scott, Karen E Weck. J Mol Diagn 2018
63
28

Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.
W Hernandez, E R Gamazon, K Aquino-Michaels, E Smithberger, T J O'Brien, A F Harralson, M Tuck, A Barbour, L H Cavallari, M A Perera. J Thromb Haemost 2017
2
50

A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance.
Ronen Loebstein, Ilana Dvoskin, Hillel Halkin, Manuela Vecsler, Aharon Lubetsky, Gideon Rechavi, Ninette Amariglio, Yoram Cohen, Gie Ken-Dror, Shlomo Almog,[...]. Blood 2007
125
14

Genetic and clinical predictors of warfarin dose requirements in African Americans.
L H Cavallari, T Y Langaee, K M Momary, N L Shapiro, E A Nutescu, W A Coty, M A G Viana, S R Patel, J A Johnson. Clin Pharmacol Ther 2010
146
14

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin.
B F Gage, C Eby, J A Johnson, E Deych, M J Rieder, P M Ridker, P E Milligan, G Grice, P Lenzini, A E Rettie,[...]. Clin Pharmacol Ther 2008
553
14

Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy.
N S Ferder, C S Eby, E Deych, J K Harris, P M Ridker, P E Milligan, S Z Goldhaber, C R King, T Giri, H L McLeod,[...]. J Thromb Haemost 2010
60
14

Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations.
Alan H B Wu, Ping Wang, Andrew Smith, Christine Haller, Katherine Drake, Mark Linder, Roland Valdes. Pharmacogenomics 2008
129
14

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.
Mitchell K Higashi, David L Veenstra, L Midori Kondo, Ann K Wittkowsky, Sengkeo L Srinouanprachanh, Fred M Farin, Allan E Rettie. JAMA 2002
789
14

Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype.
Deepak Voora, Charles Eby, Mark W Linder, Paul E Milligan, Bonny L Bukaveckas, Howard L McLeod, William Maloney, John Clohisy, R Steven Burnett, Leonard Grosso,[...]. Thromb Haemost 2005
150
14

Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy.
Benjamin D Horne, Petra A Lenzini, Mia Wadelius, Andrea L Jorgensen, Stephen E Kimmel, Paul M Ridker, Niclas Eriksson, Jeffrey L Anderson, Munir Pirmohamed, Nita A Limdi,[...]. Thromb Haemost 2012
50
14

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups.
Nita A Limdi, Mia Wadelius, Larisa Cavallari, Niclas Eriksson, Dana C Crawford, Ming-Ta M Lee, Chien-Hsiun Chen, Alison Motsinger-Reif, Hersh Sagreiya, Nianjun Liu,[...]. Blood 2010
264
14

Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans.
Roxana Daneshjou, Eric R Gamazon, Ben Burkley, Larisa H Cavallari, Julie A Johnson, Teri E Klein, Nita Limdi, Sara Hillenmeyer, Bethany Percha, Konrad J Karczewski,[...]. Blood 2014
43
14

Functional impact of CYP2C95, CYP2C96, CYP2C98, and CYP2C911 in vivo among black Africans.
Aurel C Allabi, Jean-Luc Gala, Yves Horsmans, Melih Onder Babaoglu, Atila Bozkurt, Michel Heusterspreute, Umit Yasar. Clin Pharmacol Ther 2004
72
14

In-vitro and in-vivo effects of the CYP2C9*11 polymorphism on warfarin metabolism and dose.
Guoying Tai, Frederico Farin, Mark J Rieder, Albert W Dreisbach, David L Veenstra, Christophe L M J Verlinde, Allan E Rettie. Pharmacogenet Genomics 2005
53
14

Interindividual variability in sensitivity to warfarin--Nature or nurture?
R Loebstein, H Yonath, D Peleg, S Almog, M Rotenberg, A Lubetsky, J Roitelman, D Harats, H Halkin, D Ezra. Clin Pharmacol Ther 2001
214
14

CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population.
Aurel C Allabi, Jean-Luc Gala, Yves Horsmans. Pharmacogenet Genomics 2005
84
14

A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans.
D Voora, D C Koboldt, C R King, P A Lenzini, C S Eby, R Porche-Sorbet, E Deych, M Crankshaw, P E Milligan, H L McLeod,[...]. Clin Pharmacol Ther 2010
73
14

Development of a pharmacogenetic-guided warfarin dosing algorithm for Puerto Rican patients.
Alga S Ramos, Richard L Seip, Giselle Rivera-Miranda, Marcos E Felici-Giovanini, Rafael Garcia-Berdecia, Yirelia Alejandro-Cowan, Mohan Kocherla, Iadelisse Cruz, Juan F Feliu, Carmen L Cadilla,[...]. Pharmacogenomics 2012
22
14

Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients.
P A Lenzini, G R Grice, P E Milligan, M B Dowd, S Subherwal, E Deych, C S Eby, C R King, R M Porche-Sorbet, C V Murphy,[...]. J Thromb Haemost 2008
75
14

Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin.
N A Limdi, G McGwin, J A Goldstein, T M Beasley, D K Arnett, B K Adler, M F Baird, R T Acton. Clin Pharmacol Ther 2008
186
14

Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.
Katarzyna Drozda, Shan Wong, Shitalben R Patel, Adam P Bress, Edith A Nutescu, Rick A Kittles, Larisa H Cavallari. Pharmacogenet Genomics 2015
53
14

Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans.
H Schelleman, J Chen, Z Chen, J Christie, C W Newcomb, C M Brensinger, M Price, A S Whitehead, C Kealey, C F Thorn,[...]. Clin Pharmacol Ther 2008
97
14

A pharmacogenetic versus a clinical algorithm for warfarin dosing.
Stephen E Kimmel, Benjamin French, Scott E Kasner, Julie A Johnson, Jeffrey L Anderson, Brian F Gage, Yves D Rosenberg, Charles S Eby, Rosemary A Madigan, Robert B McBane,[...]. N Engl J Med 2013
515
14

Race influences warfarin dose changes associated with genetic factors.
Nita A Limdi, Todd M Brown, Qi Yan, Jonathan L Thigpen, Aditi Shendre, Nianjun Liu, Charles E Hill, Donna K Arnett, T Mark Beasley. Blood 2015
64
14

Gamma-glutamyl carboxylase and its influence on warfarin dose.
Cristi R King, Elena Deych, Paul Milligan, Charles Eby, Petra Lenzini, Gloria Grice, Rhonda M Porche-Sorbet, Paul M Ridker, Brian F Gage. Thromb Haemost 2010
42
14

Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.
Nassr Eldin M A Shrif, Hong-Hee Won, Seung-Tae Lee, Jun-Hee Park, Ka-Kyung Kim, Min-Ji Kim, Seonwoo Kim, Soo-Youn Lee, Chang-Seok Ki, Ihsan M Osman,[...]. Eur J Clin Pharmacol 2011
32
14

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.
Minoli A Perera, Larisa H Cavallari, Nita A Limdi, Eric R Gamazon, Anuar Konkashbaev, Roxana Daneshjou, Anna Pluzhnikov, Dana C Crawford, Jelai Wang, Nianjun Liu,[...]. Lancet 2013
174
14

Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements.
Christina L Aquilante, Taimour Y Langaee, Larry M Lopez, Hossein N Yarandi, Jennifer S Tromberg, Dagmara Mohuczy, Katherine L Gaston, Cassandra D Waddell, Mark J Chirico, Julie A Johnson. Clin Pharmacol Ther 2006
220
14

Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans.
L J Dickmann, A E Rettie, M B Kneller, R B Kim, A J Wood, C M Stein, G R Wilkinson, U I Schwarz. Mol Pharmacol 2001
217
14


The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans.
M A Perera, E Gamazon, L H Cavallari, S R Patel, S Poindexter, R A Kittles, D Nicolae, N J Cox. Clin Pharmacol Ther 2011
85
14


Risks factors for highly unstable response to oral anticoagulation: a case-control study.
Gualtiero Palareti, Cristina Legnani, Giuliana Guazzaloca, Valdré Lelia, Benilde Cosmi, Barbara Lunghi, Giovanna Marchetti, Daniela Poli, Vittorio Pengo. Br J Haematol 2005
79
14

Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirement.
Alison Lh Quinn, Ina Liko, James C Lee. Pharmacogenomics 2017
6
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.